WuXi AppTec mulls gene unit sale to soften U.S. legal blow
Market talk is swirling that WuXi AppTec may be preparing to shed its cell and gene therapy business to limit potential exposure to U.S. biosecurity legislation Key Takeaways: The drug…
Recent Articles
WuXi AppTec mulls gene unit sale to soften U.S. legal blow
2359.HK
603259.SHG
